Guidelines for the use of an insulin infusion for the management of hyperglycemia in critically ill patients

OBJECTIVE:To evaluate the literature and identify important aspects of insulin therapy that facilitate safe and effective infusion therapy for a defined glycemic end point. METHODS:Where available, the literature was evaluated using Grades of Recommendation, Assessment, Development, and Evaluation (...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Critical care medicine 2012-12, Vol.40 (12), p.3251-3276
Hauptverfasser: Jacobi, Judith, Bircher, Nicholas, Krinsley, James, Agus, Michael, Braithwaite, Susan S, Deutschman, Clifford, Freire, Amado X, Geehan, Douglas, Kohl, Benjamin, Nasraway, Stanley A, Rigby, Mark, Sands, Karen, Schallom, Lynn, Taylor, Beth, Umpierrez, Guillermo, Mazuski, John, Schunemann, Holger
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:OBJECTIVE:To evaluate the literature and identify important aspects of insulin therapy that facilitate safe and effective infusion therapy for a defined glycemic end point. METHODS:Where available, the literature was evaluated using Grades of Recommendation, Assessment, Development, and Evaluation (GRADE) methodology to assess the impact of insulin infusions on outcome for general intensive care unit patients and those in specific subsets of neurologic injury, traumatic injury, and cardiovascular surgery. Elements that contribute to safe and effective insulin infusion therapy were determined through literature review and expert opinion. The majority of the literature supporting the use of insulin infusion therapy for critically ill patients lacks adequate strength to support more than weak recommendations, termed suggestions, such that the difference between desirable and undesirable effect of a given intervention is not always clear. RECOMMENDATIONS:The article is focused on a suggested glycemic control end point such that a blood glucose ≥150 mg/dL triggers interventions to maintain blood glucose below that level and absolutely
ISSN:0090-3493
1530-0293
DOI:10.1097/CCM.0b013e3182653269